LetterEffectiveness of omalizumab in severe solar urticaria
References (11)
- et al.
Solar urticaria
J Am Acad Dermatol
(2008) - et al.
Partial improvement of solar urticaria after omalizumab
J Allergy Clin Immunol
(2010) - et al.
Failure of omalizumab in ultraviolet-induced severe solar urticaria
Immunology
(2014) - et al.
Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria
Allergy
(2014) - et al.
Successful treatment of solar urticaria with anti-immunoglobulin E therapy
Allergy
(2008)
There are more references available in the full text version of this article.
Cited by (14)
Omalizumab for hypersensitive reaction to seminal plasma: A case report
2018, Allergology InternationalOmalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence
2018, Journal of Allergy and Clinical ImmunologyCitation Excerpt :The advanced search option was used with the terms “omalizumab” AND, for example, “cold urticaria” to encompass results from all fields. This was complemented by any additional published or in press evidence known to us at the time of publication (Table II).19,20,36-76 All publications have been included, regardless of whether the results were positive or negative, to present a fair and unbiased account of the available published evidence.
Response to Omalizumab in Solar Urticaria: Report of 3 Cases
2017, Actas Dermo-SifiliograficasRefractory solar urticaria successfully treated with omalizumab with normalization of phototest
2017, Actas Dermo-SifiliograficasOmalizumab in the Treatment of Chronic Inducible Urticaria
2017, Actas Dermo-SifiliograficasSolar urticaria: Epidemiology and clinical phenotypes in a Spanish series of 224 patients
2017, Actas Dermo-Sifiliograficas
Disclosures: Dr Dávila states that he has received fees as a panelist and advisory member from Novartis and Faes Farma. The other authors declare that they have no relevant conflicts of interest.
Copyright © 2016 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.